Search results
Author(s):
Noel S Lee
,
Lori B Daniels
Added:
3 years ago
Today, natriuretic peptides are ubiquitously utilized for the diagnosis, treatment, and prognostication of heart failure in the Emergency Department, as well as inpatient and outpatient settings alike.1–5 These endogenous hormones counteract some of the most detrimental effects of heart failure. Given their clinical and physiological importance, the fact that a manuscript describing the…
View more
Heart Failure Online 2022 - Day 2
Author(s):
Andrew JS Coats
,
Ileana L Piña
,
Shelley Zieroth
Start date:
May 05, 2022
Broadcast
Author(s):
Sriram D Rao
,
Srinath Adusumalli
,
Jeremy A Mazurek
Added:
3 years ago
In the article by Rao et al. entitled Pulmonary Hypertension in Heart Failure Patients (Cardiac Failure Review 2020;6:e05. https://doi.org/10.15420/cfr.2019.09), the following correction should be made.
The authors incorrectly stated that higher TAPSE/PASP correlates with “higher levels of natriuretic peptides, worse systemic and pulmonary haemodynamics and abnormal exercise aerobic capacity”,…
View more
Heart Failure Online 2022 - Day 1
Author(s):
Andrew JS Coats
,
Ileana L Piña
,
Shelley Zieroth
Start date:
May 04, 2022
Broadcast
Heart Failure Online 2022 - Day 3
Author(s):
Andrew JS Coats
,
Ileana L Piña
,
Shelley Zieroth
Start date:
May 06, 2022
Broadcast
Renata De Maria
Research Area(s) / Expertise:
Author
Expertise
HFO 2022 On-demand
Video Series
Loreena Hill
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Andrew JS Coats
,
Giuseppe Rosano
Added:
2 years ago
Following the release at ESC 2021 of updated guidelines for the diagnosis and treatment of acute and chronic heart failure, Prof Andrew Coats (Monash University, Australia and University of Warwick, UK) and Prof Giuseppe Rosano (St George's, University of London, UK) discuss the implications for treatment strategies.
This three-part series provides comprehensive update on some of the most…
View more
Peter van der Meer
Research Area(s) / Expertise:
Author